INITIATOR PHARMA: Q1 2022 REPORT
Business highlights in Q1 2022 On January 20th the initiation of dosing in the IPTN2021 program Phase 1 to assess pain reducing effects in healthy volunteers was announced. On March 22nd it was…
Financial reports
English
Annual report 2021 for Initiator Pharma A/S
Initiator Pharma’s annual report for 2021 is now available on the company´s home page
INTERIM REPORT JANUARY- JUNE 2021
Financial Highlights Initiator Pharma A/S is a Danish registered company, and is reporting its financial situation in Danish kroner (DKK). Initiator Pharma A/S was registered on May 2, 2016. Second…
INTERIM REPORT JANUARY- MARCH 2021
Business highlights in Q1 2021 On January 14[th] the EGM approved the proposed convertible financing agreement with MAC Clinical Research, covering up to SEK 23 million (approx. DKK 17 million) of…
ANNUAL REPORT 2020
Initiator Pharma’s annual report for 2020 is now available on the company’s home page http://initiatorpharma.com/investors/financial-reports/ For more information about Initiator Pharma, please…
Initiator Pharma: INITIATOR PHARMA: YEAR END REPORT 2020
Financial HighlightsInitiator Pharma A/S is a Danish registered company, and is reporting its financial situation in Danish kroner (DKK).Fourth Quarter (2020-10-01 – 2020-12-31)Net revenues were TDKK…
Initiator Pharma: INITIATOR PHARMA: Q3 2020 report
Financial HighlightsInitiator Pharma A/S is a Danish registered company, and is reporting its financial situation in Danish kroner (DKK). Initiator Pharma A/S was registered on May 2, 2016.Third…
Initiator Pharma: INITIATOR PHARMA: H1 2020 report
Financial HighlightsInitiator Pharma A/S is a Danish registered company, and is reporting its financial situation in Danish kroner (DKK). Initiator Pharma A/S was registered on May 2, 2016. Second…